Reduced prevalence of SARS-CoV-2 infection in ABO blood group O
- M. BarnkobA. Pottegård T. Barington
- 14 October 2020
Medicine
Key Points Blood group O is associated with a decreased risk for contracting SARS-CoV-2 infection.
Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study
- C. ErikstrupA. Laksafoss O. Pedersen
- 5 August 2022
Medicine, Environmental Science
The Lancet Regional Health - Europe
Screening for anti-N IgG and linkage to national registers allowed us to detect recent infections and accurately assess assay sensitivity in vaccinated or previously infected individuals during the Omicron outbreak.
Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of…
- K. M. KunisakiD. Niewoehner J. Connett
- 1 December 2016
Medicine
The timing of ART initiation has no major short-term effect on rate of lung function decline in HIV-positive individuals who are naive to ART, with CD4 T-cell counts of more than 500 per μL.
Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories
- L. HarritshøjM. Gybel-Brask R. Dessau
- 11 February 2021
Medicine
The rate of seropositivity increased with time from symptom onset and symptom severity, and a specificity of ≥99% was achieved by all total-Ab and IgG assays except one, DiaSorin Liaison XL IgG (97.2%).
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
- R. DaveyE. Fernandez-cruz J. P. Ramírez-Hinojosa
- 1 November 2019
Medicine
Summary Background Since the 1918 influenza pandemic, non-randomised studies and small clinical trials have suggested that convalescent plasma or anti-influenza hyperimmune intravenous immunoglobulin…
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
- W. SelfU. Sandkovsky Christine Wenner
- 23 December 2021
Medicine
Lancet. Infectious Diseases (Print)
Efficacy and safety outcomes were assessed in the modified intention-to-treat population, defined as all patients randomly assigned to treatment who started the study infusion and neither the sotrovimab group nor the BRII-196 plus BRII-198 group had significantly higher odds of more favourable outcomes than the placebo group.
SARS-CoV-2 antibody prevalence among homeless people, sex workers and shelter workers in Denmark: a nationwide cross-sectional study
- A. EriksenK. Fogh K. Iversen
- 10 May 2021
Medicine, Environmental Science
The prevalence of SARS-CoV-2 antibodies was more than twice as high among PEH and associated shelter workers, compared to the background population, and the subset of the study participants who were at particularly high risk of COVID-19 infection.
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV
- D. MacDonaldS. Samorodnitsky B. Wade
- 23 March 2023
Medicine
In this cohort of relatively young, recently diagnosed PWH, concentrations of pneumoproteins and biomarkers of inflammation and coagulation were not associated with subsequent rapid lung function decline and there were no significant associations between case:control status and pneumoprotein or biomarker concentrations in either virally suppressed or untreated PWH.
Psychometric properties and socio-demographic correlates of the Connor-Davidson Resilience Scale in three large population-based cohorts including Danish and Icelandic adults
- M. DidriksenH. Daníelsdóttir A. Schork
- 1 February 2025
Psychology
Journal of mood and anxiety disorders
Identifying specific factors affecting psychological resilience could be instrumental in developing new therapeutic strategies for improving and maintaining mental and physical health. To achieve…
Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic
- L. SimonsenE. Higgs M. Sands
- 8 May 2018
Medicine
Data from a clinical research network yielded accurate pandemic severity estimates, including increased severity among younger people, as well as recommendations for rapid assessment of clinical severity.
...
...